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ABSTRACT
The novel coronavirus disease 2019 (COVID-19) pandemic has caused over 33.7 million
cases and 605,000 deaths in the United States1. Factors associated with increased odds for
hospitalization, death, and other poor outcomes include age, comorbid conditions like
cardiovascular disease and lung disease, and obesity. COVID-19 has also disproportionately
affected Hispanic communities across the United States and in Omaha. Potential explanations for
this disparity include social determinants of health, particularly occupational factors, structural
challenges to access healthcare services, and increased medical comorbidities including obesity.
In this retrospective cohort study, we used patient data from April to May 2020 (N=1,000) from
a Federally Qualified Health Center with a heavily underserved and Hispanic patient base to
examine whether obesity predicted COVID-19 related ER usage and hospitalization, controlling
for relevant demographic factors, comorbidities, and social determinants of health. Our adjusted
analyses found age and BMI categories as independent predictors of ER usage and
hospitalization. These results are important for delineating communities and groups at increased
odds for negative COVID-19 outcomes and should play a role in equitable resource allocation.
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INTRODUCTION
Novel coronavirus disease 2019 (COVID-19) is an illness caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). Since the first detection of the virus in
December 2019 in Wuhan, China, it spread quickly and developed into a global pandemic. 219
countries and territories have confirmed cases of COVID-19 with over 184 million cases and
nearly 4 million deaths reported. Due to incomplete detection of the disease, particularly in
countries with less developed laboratory testing and reporting systems, the actual toll is likely
quite higher. In the United States, as of July 2021, the cumulative reported numbers are 34.0
million cases and 608,000 deaths1. Furthermore, from March 2020-February 2021 in the United
States, 574,000 more people died than in a typical year, which is 21% higher than usually
observed and over 50% higher than the reported death toll from COVID-19 over that timespan2.
SARS-CoV-2 is mainly transmitted by respiratory droplets and close contact with
infected individuals. The indolence of COVID-19 has been particularly challenging for public
health officials since the majority of individuals are asymptomatic or present mild symptoms.
However, symptoms can range from a self-limiting, mild flu-like illness with cough, sore throat
and body aches to pneumonia, acute respiratory distress syndrome, and death. Disease severity of
COVID-19 is strongly associated with underlying host conditions, particularly advanced age. A
patient’s overall health and the presence of pre-existing conditions have also been noted to affect
susceptibility and the outcome of symptomatic infections.
People with underlying uncontrolled medical conditions, those with lung, liver, and
kidney disease, cancer patients on chemotherapy, smokers, and patients on chronic
immunosuppressants including steroids are at increased risk of poor outcomes from COVID-19
infection.3 Meta-analyses tracking the comorbidities of patients hospitalized with COVID-19
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have found conditions like diabetes, cardiovascular disease, hypertension, and renal disease are
present at numbers greater than their societal prevalence and increase the risk of severe
symptoms in hospitalized patients over two fold4,5. In terms of odds ratios, cardiovascular
disease and chronic respiratory disease have the highest odds of mortality (12.83 and 7.79
respectively)6. Obesity in itself, irrespective of other comorbid conditions, has also been
identified as a risk factor for severe disease and mortality7,8. An analysis of 6.9 million adults in
England found the risk of hospitalization was 5% higher for each unit increase in BMI above 23
and the risk for ICU admission was 10% higher for each unit increase. Younger hospitalized
patients are especially likely to have comorbidities. Early CDC data found 34.6% of hospitalized
patients under the age of 50 had an underlying chronic lung disease3.
In addition to those with pre-existing conditions, the COVID-19 pandemic has been
particularly devastating for minority populations. Case, hospitalization, and death rates in the
African American, Native American, and Latino communities are higher than those for White,
Non-Hispanic persons in the United States9. In Nebraska, among results with ethnicity reported,
both COVID-19 cases and hospitalizations are twice as high in Hispanic people as Non-Hispanic
people and the death rate is 1.07 times higher despite a younger populous10. Locally in Douglas
County, 22.3% of COVID-19 cases come from Hispanic people, who make up only 13.4% of the
population11. While only 11.3% of COVID-19 deaths in Douglas County are among Hispanic
people, the average age of death is 65.9 years, significantly lower than the average age of death
of 77 years for all persons and lowest among any ethnic group11. These mirror national trends
where the COVID-19 case and mortality rates for the Hispanic population are the largest among
working-age groups and suggest occupational exposure plays a critical role in increasing
vulnerability for COVID-19 mortality12. The mechanisms of these disparities remain an
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opportunity for further inquiry, and like other health differences in health across racial and ethnic
groups, conceivably both biomedical factors and social determinants of health are involved13.
Healthy People 2030 defines social determinants of health as “the conditions in the
environments where people are born, live, learn, work, play, worship, and age that affect a wide
range of health, functioning, and quality-of-life outcomes and risks.”14. In the United States,
social determinants of health can help explain the substantial gender, racial, and ethnic
disparities present in health today15. Social determinants of health including socioeconomic
status, occupation, housing status, access to health care, and race and ethnicity can all effect
COVID-19 outcomes. With lack of effective treatment, preventative physical distancing
measures have been a mainstay of preventing the spread of COVID-19, but not all populations
may be able to successfully distance. An April 2020 New York Times analysis of smartphone
location data found people in wealthier neighborhoods were able to reduce their movement
sooner than those in poorer neighborhoods and were able to reduce their overall movement by a
greater factor. Differences in movement among different income levels were especially increased
during the workweek, echoing the suggestion suggested that people in lower-income, often
“essential” front-line jobs with face-to-face work continue movement out of economic necessity
16

. Furthermore, the disparities in movement are not just economic: less than one in five Black

workers and one in six Hispanic workers are able to work from home, compared to 30% of nonHispanic White workers17. These results are confirmed by a study that found people of color
were more likely to be employed in “essential” industries with higher exposure to infections18.
Aside from occupational risk, when controlling for age minority groups are more likely to
be affected by the aforementioned chronic medical diseases increasing risk for symptomatic and
severe disease. Minority groups are also more likely to have difficulty accessing care, use
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preventative health measures at lower rates, and are more likely to live and work in
neighborhoods conducive to unhealthy lifestyles, particularly involving tobacco use, food
deserts, and occupational exposures19. Minority groups, including Hispanics, have received
smaller shares of COVID-19 vaccinations compared to their share of cases and compared to their
share of the total population. This discrepancy has been attributed to access, rather than vaccine
hesitancy: surveys have found that among the unvaccinated, Hispanics report wanting the
vaccine at rates twice that of unvaccinated white and Black adults20.
Clearly, there exists previous research on both how social determinants of health, obesity,
and other pre-existing conditions have impacted COVID-19 severity and mortality, but so far
there is little distinction on how they interact together as comorbidities. Additionally, the
majority of studies on obesity and pre-existing conditions affecting COVID-19 outcomes have
taken place among hospitalized patients. An April 2021 literature review found only one study
focusing on the effects of obesity and comorbid conditions on COVID-19 in an outpatient
population8. Our study can add to the literature and inform practice by focusing an underserved,
minority population in an urban outpatient setting in a Midwest Federally Qualified Health
Center. Our patient population is high risk - the majority of our patient population is Hispanic,
uninsured, and 93% live below 200% of the poverty line. The primary aim of our study is to
measure the impact of obesity on COVID-19 outcomes in a majority Hispanic population at
increased risk due to social determinants of health. Our results are of interest to public health
practitioners, primary care physicians, and clinicians who have similar populations at high risk
for poor COVID-19 outcomes.
The project aims to answer the following research questions:
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1. Among patients who test positive for COVID-19 in an outpatient setting, does obesity
predict COVID-19 related emergency room (ER) usage?
2. Among patients who test positive for COVID-19 in an outpatient setting, does obesity
predict COVID-19 related hospitalization?
Our specific research aims are related to larger goals in the field of public health. We
must understand how SARS-CoV-2 interacts with other medical conditions since there will
likely be further outbreaks of similar respiratory viruses, if not SARS-CoV-2 variants. We are
still unaware of how long immunity with vaccinations will last and identifying high risk
populations is a priority. Additionally, there is a large component of social justice in this study.
Before we can reduce racial, ethnic, economic, and other health disparities, we must first identify
and recognize their existence. Quantifying these disparities allows us to assess their magnitude
and track our progress as we attempt to reduce disparities. It is important we have data on our
underrepresented populations so we ensure we can best serve people from all walks of life.
METHODS
Study Setting
OneWorld Community Health Centers is a Federally Qualified Health Center with twelve
clinics in three counties throughout the Omaha metro area. Over the last year OneWorld
Community Health Centers served 50,182 individuals. The clinic cares for patients regardless of
their ability to pay with over 51% of patients lacking medical insurance21. Furthermore, over
65% of OneWorld patients speak a language other than English as their primary language, with
the most common primary language being Spanish. Through its commitment to cultural
competence, treatment of the underserved, outreach to refugee communities, and a bilingual
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medical staff, OneWorld has developed a diverse patient base that is primarily Latino and
Spanish-speaking.
Towards the onset of the COVID-19 pandemic, OneWorld uncovered many of the initial
cases in Nebraska from patients working in meatpacking plants and other large industrial
facilities. Along with partnerships through the National Guard, Douglas County Health
Department, and Nebraska Medicine, OneWorld began operating free COVID PCR testing sites
in South Omaha. As of April 2021, OneWorld had administered a cumulative 14,723 COVID
tests with a 32% case positivity rate. All patients who underwent testing had electronic medical
records created for their results and contact tracers gathered information on symptoms,
exposures, prior medical conditions, and household size. Further information regarding outcomes
is available thanks to medical record review of case management and patient follow-up.
Study Design
To evaluate the effects of increased BMI on COVID outcomes, we conducted a
retrospective cohort study beginning with all patients who had been diagnosed with COVID-19
based on positive laboratory test results at a OneWorld testing site or with diagnostic codes
indicating a diagnosis of COVID-19 in the OneWorld electronic medical record system from
March to May 2020. Our sample was restricted to non-pregnant patients who were at least 18
years old, had a previous medical visit at OneWorld prior to their COVID-19 test, and had BMI
data available within the two years prior or six months following their COVID-19 diagnosis.
Electronic medical records provided access to subject data for BMI, diagnostic history,
demographic characteristics, social determinants of health, and COVID-19 outcomes. The
institutional review board approved the exempt study and waiver of consent.
Measures
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BMI: The BMI measurement at the date of diagnosis or the value closest to that date was
selected. Body mass index was calculated by kilograms (kg)/meters (m)2. The World Health
Organization (WHO) categories for overweight and obesity were used22.
Comorbidities: Clinical risk factors followed included tobacco use and diagnoses of asthma,
cerebrovascular disease, congestive heart failure (CHF), chronic obstructive pulmonary disease
(COPD), diabetes mellitus, hypertension, dyslipidemia, malignancy, coronary artery disease
(CAD), organ transplant status, peripheral vascular disease (PVD), and renal disease.
Comorbidities were tracked by the presence of an ICD-10 code in the electronic medical records
or patient affirmation of comorbid conditions when informed of their COVID-19 diagnosis.
Demographic Characteristics: Demographic factors including race/ethnicity, sex, age, household
size, and preferred language were tracked. Factors were obtained directly from electronic
medical records.
Social Determinants of Health: We considered social determinants of health including insurance
status, zip code, and whether the patient worked in an industry at high risk for COVID. Insurance
status and zip code were obtained from each patient’s billing information. Occupation was
obtained from interviews with the patients conducted while informing of their COVID-19
diagnosis. Industries considered high risk included meatpacking, healthcare, and residential
assisted living facilities.
COVID-19 Outcomes
Outcomes tracked included ER visits, hospitalizations, and death directly related to COVID-19
infection. Outcomes were gathered from notes in the patient medical records and the Nebraska
Health Information Initiative, a statewide exchange for clinical data.
Data Analysis
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We controlled for other chronic diseases that have been associated with increased risk of
severe COVID infection. Data was additionally controlled for age, gender, race and ethnicity and
income level. Week of diagnosis was included as a covariate to adjust for changes in testing
practices, social distancing recommendations, and potential changes in clinical management
throughout the study period. Since the frequency of death was so low in our sample, analyses
were only conducted for ER visits and hospital admissions.
Each covariate and outcome were assessed in a series of bivariate analyses, comparing
those who visited the ER, were hospitalized, or died using a Chi-Squared analysis or Fisher exact
test depending on expected count. All independent variables that were statistically significant at
the p < 0.05 level were included in the adjusted analysis. Adjusted odds ratios for each outcome
tracked were generated for different BMI categories and selected social determinants of health
using multivariable logistic regression8. All analyses were done using SPSS statistical software
version 27.0.
RESULTS
We identified 1,000 patients with COVID-19 diagnoses on dates ranging from 04/02/202005/22/2020. Cases were identified by a positive result on polymerase chain reaction testing
performed by OneWorld Community Health Centers or the Nebraska National Guard. Of these
1,000 patients, 538 fit inclusion criteria. Overall, the majority of patients in our sample were White
(92.6%), Hispanic (94.4%), and Spanish-speaking (84.0%) (Table 1). Our sample had a slight
female preponderance (58%). At our index date, the mean age was 40.6 years (SD=13.4), and the
mean BMI was 30.83 (SD=6.53). On average, BMIs were taken 171.9 days apart from the date of
diagnosis. Our sample was primarily uninsured (58.4%), and a large percentage were employed in
a high-risk occupation (37.9%). The most prevalent comorbidities were dyslipidemia (23.8%),
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diabetes mellitus (18.2%), hypertension (15.6%), asthma (4.8%), and renal disease (4.6%). A total
of 57 (10.6%) patients from our sample visited the ER, 31 (5.8%) were admitted to a hospital, and
5 (0.9%) died.
We detected a statistically significant interaction between categorical BMI and categorical
age (p < 0.001) and between categorical BMI and sex (p = 0.029). Analyses comparing week of
diagnosis to each outcome found no significant results (p = 0.649, 0.853 for ER visits and hospital
admissions respectively). When age was stratified into ten-year age categories, significant
associations were found with both ER visits and hospital admissions. Aside from age, no
significant associations were detected between demographic characteristics and social
determinants of health aside from an association between payer and the odds of hospitalization.
The covariates selected for our adjusted models were those present in more than ten individual
patients showing significant associations using the Chi-square or Fisher exact tests for each
outcome.
Adjusted Analysis for ER visits
For ER visits, covariates included: age category, BMI category (WHO), diabetes mellitus,
hypertension, dyslipidemia, and renal disease (Table 2). We noted significant associations between
age category and ER visits, but not with BMI category and ER visits or our selected comorbidities.
In adjusted analyses, an underweight BMI was associated with higher odds for ER visits, while
increasing BMI category above overweight showed increased odds of an ER visit as well.
Adjusted Analysis for Hospitalizations
For hospitalizations, covariates included: age category, BMI categories (WHO), payer
status, diabetes mellitus, dyslipidemia, hypertension, and renal disease. Significant associations
were noted between both age and BMI categories with hospitalizations. Differences between BMI
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categories were pronounced, with BMI categories between Normal and Obese Class II showing
significantly lower odds for hospitalization than Obese Class III.
DISCUSSION
Overall, our sample reported similar rates of hospitalization and lower death rates than
were present in the state of Nebraska at large at the end of our study period (5.8% and 1.2% of
those tested in the same period respectively)23. Our average age was lower than the average age
of all adults testing positive for COVID-19 in Douglas County during the time frame of our
study with notably fewer patients over the age of 70, the population at highest risk for
hospitalization and mortality11. ER visits due to COVID-19 have not been tracked on a national
or local scale and are a more subjective endpoint than hospitalizations or death rates. All patients
in the study were contacted by medical staff at OneWorld for triage of symptoms at intervals
judged appropriate with a COVID Severity rating scale. Patients with concerning symptoms
would be frequently referred to an urgent triage visit at OneWorld or advised to report to the ER.
While not all patients followed these guidelines, the application of objective criteria guiding ER
recommendations makes it a more measurable endpoint for tracking.
The associations we found between BMI and the odds for ER visits and hospitalizations
show that BMI is an independent risk factor for negative outcomes associated with COVID-19
diagnosis in our primarily Hispanic and uninsured patient sample. These associations were
independent of obesity-related comorbidities and potential confounders. Importantly, the odds
for negative outcomes increased with ascending BMI categories. Medical comorbidities
frequently associated with obesity in metabolic syndrome like diabetes mellitus, dyslipidemia,
hypertension, and renal disease all showed initial associations with negative outcomes, but when
adjusted for other factors with logistic regression did not show significance. While the
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Underweight BMI category showed increased odds for both ER visits and hospitalization, the
adjusted odds were not significant at a 95% confidence interval, likely due to the low count of
underweight patients in our sample.
With the relative rarity of negative events associated with COVID-19, it is possible our
sample size was not large enough to elucidate associations found between demographic
characteristics, social determinants of health, and medical comorbidities seen in other studies.
Significant associations between COPD, CAD, congestive heart failure, and peripheral vascular
disease and negative COVID-19 outcomes were detected, but because few patients in our sample
reported these comorbid conditions they were not included in our adjusted analyses. Other
conditions like cerebrovascular disease, malignancy, and organ transplant were found at too low
of rates in our population to draw conclusions. While asthma was present, the younger average
age of the patients diagnosed with asthma in our sample likely played a role in the rarity of
negative events associated with asthma.
As a whole our patient population had an increased prevalence of some comorbidities
with obesity and diabetes mellitus rates higher than the surrounding metro area (48.1% and
18.2% vs 33.5% and 11.2% respectively)24. Other comorbidities in our sample including heart
disease, cerebrovascular disease, cancer, and COPD appeared at rates much lower than the
surrounding community, possibly reflecting the relatively young average age of our sample. Selfreported tobacco use is much lower than is reported in the surrounding population24. There also
exists the possibility that selection bias has occurred in the form of our study population’s high
rates of manual labor work. The vast majority of patients categorized as high-risk worked in
meat packing facilities, which require physical strength and stamina. Though these conditions
leave patients at increased risk for acute injuries and long-term health problems, a person cannot
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perform the job without the capacity for physical exertion which is protective against respiratory
diseases. Finally, it is possible these comorbidities are present, but undiagnosed in our patient
population who through lack of insurance does not always have access to diagnostic testing. As
seen in the lengthy average time since patients had BMI measurements taken, many of the
patients in our sample do not frequently access healthcare.
Though we did not find significant adjusted effects for our demographic characteristics or
social determinants of health, this does not mean they have not played a role in our outcomes.
We attribute or lack of demographic significance to a lack of diversity in our heavily White,
Hispanic, Spanish-speaking patient population and the lack of large comparison groups in other
ethnic or racial categories. While mortality was too rare of an event in our sample to adequately
track associations, comparing the outcomes of our primarily Spanish-speaking population with
the population at large may yield disparities since the primary public testing organization in
Nebraska initially lacked Spanish speaking staff. A larger sample size would provide greater
power to uncover associations between social determinants of health and outcomes we believe
are currently masked. While our sample size is somewhat large, the outcomes we tracked,
especially death, were exceedingly rare and a larger sample size would likely provide a clearer
picture. It is our hope that further analysis using more of OneWorld’s COVID-19 database will
be able to provide a more granular look into risk factors for poor COVID-19 outcomes from both
a medical lens and with social determinants of health.
CONCLUSION
In summary, our study contributes to the general understanding of obesity’s effects on
adverse COVID-19-associated outcomes. Our results agreed with other studies that determined
obesity was an independent risk factor for poor COVID-19 outcomes. We have evidence that our
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sample, though younger, suffered similar rates of hospitalization as the community as the
community at large. Obesity, especially morbid obesity, independently increased the odds for
negative outcomes in our population, explaining at least some of this disparity. Many of the same
social determinants of health putting our population at higher risk for obesity have been found to
independently increase the risk for negative COVID-19 outcomes as well. As we move forward
promoting vaccinations as the best defense against COVID-19 infection and poor outcomes, it is
important to use this knowledge to better target communities and groups at high risk for poor
COVID-19 outcomes so that we ensure equitable distribution of resources.
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